Response to the Letter: "Transdermal vs oral estrogen therapy and venous thromboembolism: upgrade the level of evidence" by Scarabin MC, et al

Affiliations

¹ Evidence-Based Practice Research Program, Center for the Science of Health Care Delivery, and Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota 55905.

Comment

Khaled Mohammed et al. J Clin Endocrinol Metab. 2016 Feb.

. 2016 Feb;101(2):L32.

doi: 10.1210/jc.2015-4377.

¹ Evidence-Based Practice Research Program, Center for the Science of Health Care Delivery, and Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota 55905.

No abstract available

Comment on

Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
Mohammed K, Abu Dabrh AM, Benkhadra K, Al Nofal A, Carranza Leon BG, Prokop LJ, Montori VM, Faubion SS, Murad MH. Mohammed K, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):4012-20. doi: 10.1210/jc.2015-2237. J Clin Endocrinol Metab. 2015. PMID: 26544651
Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by.
Scarabin PY, Canonico M, Scarabin-Carré V, Oger E. Scarabin PY, et al. J Clin Endocrinol Metab. 2016 Feb;101(2):L30-1. doi: 10.1210/jc.2015-4248. J Clin Endocrinol Metab. 2016. PMID: 26840115 No abstract available.